NCT02973126View on ClinicalTrials.gov

Heartflow (AFFECTS)

PHASE3UnknownINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Cardiovascular Abnormalities
Interventions
PROCEDURE

FFRct and SPECT

enable the comparison of diagnostic performance of FFRct and SPECT in subjects with suspected stable CAD after abnormal SPECT imaging who have no contraindications to coronary computed tomography angiography (CCTA).

Trial Locations (1)

75093

The Heart Hospital Baylor Plano, Plano

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER